MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Non-Ketotic Hyperglycemic Hemichorea as an initial manifestation of type 2 diabetes

P. Karau, J. Hooker, G. Mbijiwe (Meru, Kenya)

Meeting: MDS Virtual Congress 2020

Abstract Number: 69

Keywords: Basal ganglia, Hemiballism, Hemichorea

Category: Choreas (Non-Huntington's Disease)

Objective: To diagnose and characterize Non-ketotic Hyperglycemic Hemichorea as a first symptom of type 2 Diabetes using phenomenology and imaging

Background: Non-Ketotic Hyperglycemic Hemichorea is a rare movement disorder associated with uncontrolled diabetes mellitus. It has been reported in type 2 diabetes, and much rare in type 1 diabetes mellitus. It is characterized by hemichorea-hemiballism that resolves with glycemic control, though some cases may be unremitting. It has hardly been reported as the presenting complaint in a new diagnosis of diabetes mellitus. 

Method: We hereby discuss a case of NKHCB as a first complaint in a 52 year old lady not previously known to have diabetes. She presented to our hospital with 1 month history of involuntary movements of the right upper and lower limbs. She had no history of trauma, stroke or hypertension, and she was alert. The movements interfered with feeding and ambulation. Her examination revealed right-sided periodic choreiform and ballistic movements, suppressed by sleep. She had normal motor power, reflexes and preserved sensation over all dermatomes.

Results: Chemisty revealed normal sodium of 136mmol/l, BUN of 7.0mmol/L, calcium of 2.30mmol/L, and creatinine of 81umol/L. Her random blood glucose was 33.0mmol/L, and HbA1c of 11.0%. Her blood count showed white blood cell of 7.5 with no left shift, hemoglobin of 14.2g/dl and ESR of 14mm/hr. She had normal thyroid and hepatic function panels. CSF studies revealed normal proteins and glucose. The CT scan did not reveal any abnormality. An MRI showed a T1 hyperintensity on the left lentiform nucleus, with normal attenuation in T2 and DW sequences. Our patient was initiated on regular insulin with dose titration until euglycemia was achieved. She was also started on haloperidol due to the distressing abnormal movements, but this was withdrawn after 3 days because of adverse effects. The symptoms gradually improved with a complete resolution at 6 weeks. Her glycemic control remains excellent on lantus (glargine) insulin and metformin.

Conclusion: In conclusion, non-ketotic hyperglycemic hemichorea is a rare but important differential to consider in patients presenting with hemichorea-hemiballism. Prompt diagnosis carries an excellent diagnosis. All patients with this presentation should be screened for diabetes mellitus.

To cite this abstract in AMA style:

P. Karau, J. Hooker, G. Mbijiwe. Non-Ketotic Hyperglycemic Hemichorea as an initial manifestation of type 2 diabetes [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/non-ketotic-hyperglycemic-hemichorea-as-an-initial-manifestation-of-type-2-diabetes/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/non-ketotic-hyperglycemic-hemichorea-as-an-initial-manifestation-of-type-2-diabetes/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley